These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6574831)

  • 21. Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
    Demirer T; Buckner CD; Appelbaum FR; Bensinger WI; Sanders J; Lambert K; Clift R; Fefer A; Storb R; Slattery JT
    Bone Marrow Transplant; 1996 Apr; 17(4):491-5. PubMed ID: 8722344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic myeloid leukemia during pregnancy successfully treated with busulfan].
    COERS RJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1935-6. PubMed ID: 13810863
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diabetes insipidus in chronic myeloid leukemia. Remission of hypophyseal infiltration during busulfan treatment].
    Eichhorn P; Rhyner K; Haller D; Hämmerli R; Steuli R; Furrer J
    Schweiz Med Wochenschr; 1988 Feb; 118(8):275-9. PubMed ID: 3162777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [SUPPORTIVE THERAPY IN CHRONIC MYELOCYTIC LEUKEMIA].
    BALGOZHINA ShZh
    Sov Med; 1964 Nov; 27():3-8. PubMed ID: 14311420
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of chronic myeloid leukemia with Mannit-busulfan].
    GRAF F; TAKACSI-NAGY L
    Orv Hetil; 1961 Sep; 102():1849-51. PubMed ID: 13900978
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolism of 14C-busulfan in isolated perfused rat liver.
    Hassan M; Ehrsson H
    Eur J Drug Metab Pharmacokinet; 1987; 12(1):71-6. PubMed ID: 3609074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [High-dose busulfan with subsequent bone marrow transplantation in poor-risk forms of leukemia].
    Urban C; Slavc I; Kaulfersch W; Teubl I
    Wien Klin Wochenschr; 1987 Mar; 99(5):144-9. PubMed ID: 3554777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aplasia of the bone marrow in patients with chronic myelocytic leukemia treated with myelosan].
    POGOSIAN AS
    Probl Gematol Pereliv Krovi; 1962 Nov; 7():50-2. PubMed ID: 13944217
    [No Abstract]   [Full Text] [Related]  

  • 29. Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Czerw T; Pabst T; Blaise D; Dumas PY; Nemet D; Arcese W; Trisolini SM; Wu D; Huynh A; Zuckerman T; Meijer E; Cagirgan S; Cornelissen J; Houhou M; Polge E; Mohty M; Nagler A
    Cancer; 2017 Mar; 123(5):824-831. PubMed ID: 27906458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haloperidol kinetics after oral and intravenous doses.
    Holley FO; Magliozzi JR; Stanski DR; Lombrozo L; Hollister LE
    Clin Pharmacol Ther; 1983 Apr; 33(4):477-84. PubMed ID: 6831826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytologic dysplasia related to busulfan (Myleran) therapy. Report of a case.
    GURELI N; DENHAM SW; ROOT SW
    Obstet Gynecol; 1963 Apr; 21():466-70. PubMed ID: 13951337
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetics and absolute bioavailability of atenolol.
    Mason WD; Winer N; Kochak G; Cohen I; Bell R
    Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
    Preisler HD; Kirshner J
    Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DIHYDROXYBUSULFAN (NSC-39069) IN CHRONIC MYELOCYTIC LEUKEMIA AND MISCELLANEOUS MALIGNANT NEOPLASMS.
    LOEB V
    Cancer Chemother Rep; 1964 Nov; 42():39-43. PubMed ID: 14226129
    [No Abstract]   [Full Text] [Related]  

  • 35. Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation.
    Deneer VH; Lie-A-Huen L; Kingma JH; Proost JH; Gossen SA; Stuurman A; Uytdehaag GM; Dunselman PH; Brouwers JR
    Eur J Clin Pharmacol; 2004 Dec; 60(10):693-701. PubMed ID: 15619132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of alpha-difluoromethylornithine: an irreversible inhibitor of ornithine decarboxylase.
    Haegele KD; Alken RG; Grove J; Schechter PJ; Koch-Weser J
    Clin Pharmacol Ther; 1981 Aug; 30(2):210-7. PubMed ID: 6788425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Busulfan conjugation by glutathione S-transferases alpha, mu, and pi.
    Czerwinski M; Gibbs JP; Slattery JT
    Drug Metab Dispos; 1996 Sep; 24(9):1015-9. PubMed ID: 8886613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Casuistics on myleran treatment in chronic myelocytic leukemia].
    KOSENOW W
    Arch Kinderheilkd; 1956; 153(3):251-4. PubMed ID: 13355417
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biopharmaceutic investigations with D-norpseudoephedrine (author's transl)].
    Frosch F
    Arzneimittelforschung; 1977; 27(3):665-8. PubMed ID: 577442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STEROID HORMONE METABOLISM IN CHRONIC MYELOGENOUS LEUKEMIA.
    GALLAGHER TF; HELLMAN L; ZUMOFF B; MILLER DG
    Blood; 1965 May; 25():743-8. PubMed ID: 14282043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.